Package 68001-572-41

Brand: bendamustine hydrochloride

Generic: bendamustine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68001-572-41
Digits Only 6800157241
Product NDC 68001-572
Product ID 68001-572_14ca6252-d081-3bdf-e063-6394a90abb8d
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (68001-572-41) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2023-10-15
Brand bendamustine hydrochloride
Generic bendamustine hydrochloride
Sample Package No

Linked Drug Pages (1)

bendamustine hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "14ca6252-d081-3bdf-e063-6394a90abb8d", "openfda": {"upc": ["0368001572415", "0368007511418"], "unii": ["981Y8SX18M"], "rxcui": ["1805001", "1805007"], "spl_set_id": ["0df025d2-c093-427a-b599-f605e71fe835"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68001-572-41)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68001-572-41", "marketing_start_date": "20231015"}], "brand_name": "bendamustine hydrochloride", "product_id": "68001-572_14ca6252-d081-3bdf-e063-6394a90abb8d", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Alkylating Activity [MoA]", "Alkylating Drug [EPC]"], "product_ndc": "68001-572", "generic_name": "bendamustine hydrochloride", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bendamustine hydrochloride", "active_ingredients": [{"name": "BENDAMUSTINE HYDROCHLORIDE", "strength": "100 mg/20mL"}], "application_number": "ANDA205574", "marketing_category": "ANDA", "marketing_start_date": "20230915", "listing_expiration_date": "20261231"}